This inventor holds 1 USPTO granted patent. Top assignees: Kawasumi Laboratories. Inc., Kuraray Co., Ltd.. Active years: 1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1979
Title: Yutaka Sakurada: Innovator in Semi-Permeable Membranes
Introduction
Yutaka Sakurada is a notable inventor based in Kyoto, Japan. He is recognized for his contributions to the field of semi-permeable membranes, particularly those made from regenerated cuprammonium cellulose. His innovative work has significant implications for medical applications, especially in the dialysis of body fluids.
Latest Patents
Yutaka Sakurada holds a patent for semi-permeable membranes of regenerated cuprammonium cellulose. This patent describes a process where these membranes are subjected to wet-heat sterilization at temperatures ranging from 105 to 140 degrees Celsius. During this treatment, the membranes are kept in contact with an aqueous medium, such as water or physiological saline. The resulting hollow fiber, semi-permeable membranes exhibit a sonic modulus of at least 6.5 × 1010 dynes/cm2, making them particularly effective for dialysis applications. Hollow fibers made of cuprammonium regenerated cellulose are especially preferred for this purpose.
Career Highlights
Throughout his career, Yutaka Sakurada has worked with prominent companies, including Kuraray Co., Ltd. and Kawasumi Laboratories, Inc. His expertise in the development of advanced materials has positioned him as a key figure in the innovation of medical technologies.
Collaborations
Yutaka has collaborated with notable individuals in his field, including Kimihisa Sunahara and Kazuhisa Yamauchi. These collaborations have contributed to the advancement of research and development in semi-permeable membranes.
Conclusion
Yutaka Sakurada's work in the field of semi-permeable membranes has made a significant impact on medical technology. His innovative approaches and collaborations continue to influence advancements in dialysis and other applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile